Lee CH - Search Results

1

Relation between door-to-balloon time and microvascular perfusion as evaluated by myocardial blush grade, corrected TIMI frame count, and ST-segment resolution in treatment of acute myocardial infarction.

Lee CH, Tai BC, Lau C, Chen Z, Low AF, Teo SG, Tan HC. Lee CH, et al. J Interv Cardiol. 2009 Oct;22(5):437-43. doi: 10.1111/j.1540-8183.2009.00493.x. Epub 2009 Jul 13. J Interv Cardiol. 2009. PMID: 19674244 Free article.

2

Predictors of survival after contemporary percutaneous coronary revascularization for acute myocardial infarction in the real world.

Lee CH, van Domburg RT, Hoye A, Lemos PA, Tanabe K, Smits PC, van der Giessen WJ, de Feyter P, Serruys PW. Lee CH, et al. J Invasive Cardiol. 2004 Nov;16(11):627-31. J Invasive Cardiol. 2004. PMID: 15550731

3

Safety and feasibility of X-sizer-facilitated rescue percutaneous coronary intervention: a preliminary experience.

Lee CH, Tan HC, Teo SG, Sutandar A, Lim YT. Lee CH, et al. J Invasive Cardiol. 2005 Jan;17(1):1-4. J Invasive Cardiol. 2005. PMID: 15640528

4

Impact of glycemic control on occurrence of no-reflow and 30-day outcomes in diabetic patients undergoing primary angioplasty for myocardial infarction.

Lee CH, Teo SG, Hong E, Wong HB, Low A, Sutandar A, Tan HC, Lim YT. Lee CH, et al. J Invasive Cardiol. 2005 Aug;17(8):422-6. J Invasive Cardiol. 2005. PMID: 16079448

5

Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.

Lee CH, Wong HB, Tan HC, Zhang JJ, Teo SG, Ong HY, Low A, Sutandar A, Lim YT. Lee CH, et al. J Interv Cardiol. 2005 Aug;18(4):261-6. doi: 10.1111/j.1540-8183.2005.00041.x. J Interv Cardiol. 2005. PMID: 16115155 Free article.

6

Pseudo-no-reflow phenomenon in ostial saphenous vein graft intervention using FilterWire EX protection.

Lee CH, Low A, Tan HC, Lim YT. Lee CH, et al. Int J Cardiol. 2005 Sep 30;104(2):233-4. doi: 10.1016/j.ijcard.2004.10.063. Int J Cardiol. 2005. PMID: 16168821

7

Update on drug-eluting stents for prevention of restenosis.

Lee CH, Tan HC, Lim YT. Lee CH, et al. Asian Cardiovasc Thorac Ann. 2006 Feb;14(1):75-82. doi: 10.1177/021849230601400120. Asian Cardiovasc Thorac Ann. 2006. PMID: 16432127 Review.

8

Procedural success and 30 day outcomes between CYPHER and TAXUS stent implantation for the treatment of bifurcation lesions--a single-center experience.

Lee CH, Tan HC, Bee H, Zhang JJ, Soon CY, Teo SG, Low A, Lim YT. Lee CH, et al. J Invasive Cardiol. 2006 Feb;18(2):39-42. J Invasive Cardiol. 2006. PMID: 16446512

9

CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days-long-term follow-up results.

Lee CH, Low A, Lim J, Wong HB, Lim YT, Tan HC. Lee CH, et al. Int J Cardiol. 2007 May 2;117(3):422-4. doi: 10.1016/j.ijcard.2006.05.065. Epub 2006 Aug 9. Int J Cardiol. 2007. PMID: 16904214 No abstract available.

10

Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study.

Lee CH, Low A, Tai BC, Co M, Chan MY, Lim J, Lim YT, Tan HC. Lee CH, et al. Eur Heart J. 2007 Jan;28(1):19-25. doi: 10.1093/eurheartj/ehl411. Epub 2006 Nov 28. Eur Heart J. 2007. PMID: 17132650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,920 results

Search Page

Filters